Dallanoce_2011_ChemMedChem_6_889

Reference

Title : Design, synthesis, and pharmacological characterization of novel spirocyclic quinuclidinyl-Delta2-isoxazoline derivatives as potent and selective agonists of alpha7 nicotinic acetylcholine receptors - Dallanoce_2011_ChemMedChem_6_889
Author(s) : Dallanoce C , Magrone P , Matera C , Frigerio F , Grazioso G , De Amici M , Fucile S , Piccari V , Frydenvang K , Pucci L , Gotti C , Clementi F , De Micheli C
Ref : ChemMedChem , 6 :889 , 2011
Abstract :

A set of racemic spirocyclic quinuclidinyl-Delta(2)-isoxazoline derivatives was synthesized using a 1,3-dipolar cycloaddition-based approach. Target compounds were assayed for binding affinity toward rat neuronal homomeric (alpha7) and heteromeric (alpha4beta2) nicotinic acetylcholine receptors. Delta(2) -Isoxazolines 3 a (3-Br), 6 a (3-OMe), 5 a (3-Ph), 8 a (3-OnPr), and 4 a (3-Me) were the ligands with the highest affinity for the alpha7 subtype (K(i) values equal to 13.5, 14.2, 25.0, 71.6, and 96.2 nM, respectively), and showed excellent alpha7 versus alpha4beta2 subtype selectivity. These compounds, tested in electrophysiological experiments against human alpha7 and alpha4beta2 receptors stably expressed in cell lines, behaved as partial alpha7 agonists with varying levels of potency. The two enantiomers of (+/-)-3-methoxy-1-oxa-2,7-diaza-7,10-ethanospiro[4.5]dec-2-ene sesquifumarate 6 a were prepared using (+)-dibenzoyl-L- or (-)-dibenzoyl-D-tartaric acid as resolving agents. Enantiomer (R)-(-)-6 a was found to be the eutomer, with K(i) values of 4.6 and 48.7 nM against rat and human alpha7 receptors, respectively.

PubMedSearch : Dallanoce_2011_ChemMedChem_6_889
PubMedID: 21365765

Related information

Citations formats

Dallanoce C, Magrone P, Matera C, Frigerio F, Grazioso G, De Amici M, Fucile S, Piccari V, Frydenvang K, Pucci L, Gotti C, Clementi F, De Micheli C (2011)
Design, synthesis, and pharmacological characterization of novel spirocyclic quinuclidinyl-Delta2-isoxazoline derivatives as potent and selective agonists of alpha7 nicotinic acetylcholine receptors
ChemMedChem 6 :889

Dallanoce C, Magrone P, Matera C, Frigerio F, Grazioso G, De Amici M, Fucile S, Piccari V, Frydenvang K, Pucci L, Gotti C, Clementi F, De Micheli C (2011)
ChemMedChem 6 :889